Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Technology”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 163 records · Page 9Linked to original sources

Epoetin alfa: patient management issues and development through recombinant DNA technology. Part 1: Focus on Epoetin alfa patient management and recombinant DNA technology.

The emergence of the Epoetin alfa as an effective therapy in the treatment of the anemia of chronic renal failure has reemphasized the importance of nursing monitoring and intervention in the treatment of these patients. This article examines the role of nurses in monitoring and managing patients receiving Epoetin alfa and the development of medications, such as Epoetin alfa, with recombinant DNA technology.

Anemia, Hypochromic↗

Gamma processing technology: an alternative technology for terminal sterilization of parenterals.

This paper will outline the advantages of utilizing gamma radiation as a means for terminally sterilizing parenterals and other pharmaceutical products. The factors which must be evaluated in order to qualify a product for radiation sterilization will be detailed. It will also compare the characteristics of this method with other technologies currently available. The highest SAL can be achieved by combining a knowledge of the microbial quality of the raw materials, and the manufacturing environment with a formulation designed to promote the most radiation stable form of the product.

Gamma Rays↗

[The technology for manufacturing antiparasitic preparations. 1. The development of a technology for producing the anthelmintic triklazan in finely dispersed form and the evaluation of its antinematodal, anticestodal and antitrematodal activities].

The authors describe the technology of preparing a new anthelmintic agent triclazan, N-(3,4-dichlorophenyl)-2-[(benzo-2,1,3-thiadiazole-4-sulfonyl)amino]-5- chlorobenzamide, finely dispersed (the particles size 4-8 mu). Triclazan is highly effective not only in hymenolepiasis and trichocephaliasis, as was shown previously, but in fascioliasis, monieziasis and intestinal nematodiasis of sheep as well.

Animals↗

New ideas and advancing technologies in periodontology: surgical options with advancing technologies.

Extensive clinical studies over the last two decades have documented the effectiveness of both non-surgical and surgical periodontal therapy. When deemed necessary, surgery is usually performed as an elective phase of therapy, within a programme of ongoing maintenance care. Traditionally surgical therapy has been aimed at the treatment of the periodontal pocket by resective procedures. However, research has now focused on reconstructive surgery, with the objective of regenerating the structure of the lost periodontium (cementum, periodontal ligament and also alveolar bone). With advancing technology, materials and surgical modalities that have been advocated to facilitate periodontal reconstruction fall into the following main categories: 1. Chemical and biochemical conditioning agents, e.g. citric acid, fibronectin, tetracycline, growth and differentiation factors. 2. Transplants of autogenous or allogeneic (osteogenic or osteoinductive) materials, e.g. osseous coagulum, decalcified freeze-dried bone allograft. 3. Implants of alloplastic (osteoconductive) 'filler' materials, e.g. hydroxyapatite, tricalcium phosphate. 4. Guided tissue regeneration (GTR) utilising membranes, e.g. Teflon (e-PTFE), collagen, polylactic acid. 5. Combined techniques, e.g. GTR and allograft/alloplast. The scientific evaluation and the role of these reconstructive surgical procedures in contemporary dental practice is discussed in this paper.

Alveoloplasty↗